BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6822408)

  • 1. Molecular distribution of preformed thyroglobulin immune complexes.
    Husby S; Steensgaard J; Feldt-Rasmussen U; Date J
    Immunology; 1983 Feb; 48(2):401-9. PubMed ID: 6822408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer simulation of immunochemical interactions.
    Steensgaard J; Johansen HK; Moller NP
    Immunology; 1975 Sep; 29(3):571-9. PubMed ID: 1165112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The properties of immune complex-forming systems. A new theoretical approach.
    Steensgaard J; Liu BM; Cline GB; Møller NP
    Immunology; 1977 Apr; 32(4):445-56. PubMed ID: 608678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubility properties of IgG immune complexes. Comparison between the effects of low molecular weight solvents and polyethylene glycols.
    Johansen AS; Steensgaard J; Jacobsen C
    Immunology; 1980 Nov; 41(3):695-704. PubMed ID: 7461709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of soluble immune complexes prepared from oligovalent DNP conjugates and anti-DNP antibodies.
    Kijlstra A; Knutson DW; van der Lelij A; van Es LA
    J Immunol Methods; 1977; 17(3-4):263-77. PubMed ID: 915301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Suppression of thrombocyte aggregation by immune complexes. II. The effect of preformed immune complexes on thrombocyte aggregation].
    Osipov SG; Turlubekov KK; Titov VN; Rudnev VI; Shkhvatsabaia IK
    Biull Eksp Biol Med; 1983 Feb; 95(2):21-3. PubMed ID: 6824768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human platelet-immune complex interaction in plasma.
    Clark WF; Tevaarwerk GJ; Reid BD
    J Lab Clin Med; 1982 Dec; 100(6):917-31. PubMed ID: 6982951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet aggregation and release associated with immune complex formation in pig plasma.
    Clark WF; Tevaarwerk GJ; Bandali K; Lindsay RM; Linton AL
    J Lab Clin Med; 1980 Oct; 96(4):654-65. PubMed ID: 7419956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization of synthesized thyroglobulin immune complexes (IC). A model for studies of IC containing an autoantigen.
    Feldt-Rasmussen U; Husby S; Blåbjerg O; Date J; Nielsen H
    Allergy; 1981 Feb; 36(2):107-13. PubMed ID: 7235202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic analysis of the effects of small inert cosolutes in the ultracentrifugation of noninteracting proteins.
    Jacobsen MP; Wills PR; Winzor DJ
    Biochemistry; 1996 Oct; 35(40):13173-9. PubMed ID: 8855955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation, distribution, and elimination of infliximab and anti-infliximab immune complexes in cynomolgus monkeys.
    Rojas JR; Taylor RP; Cunningham MR; Rutkoski TJ; Vennarini J; Jang H; Graham MA; Geboes K; Rousselle SD; Wagner CL
    J Pharmacol Exp Ther; 2005 May; 313(2):578-85. PubMed ID: 15647331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretation of the Raji cell assay in sera containing anti-nuclear antibodies and immune complexes.
    Horsfall AC; Venables PJ; Mumford PA; Maini RN
    Clin Exp Immunol; 1981 May; 44(2):405-15. PubMed ID: 6975676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A theoretical approach to precipitin reactions: insight from computer simulation.
    Steensgaard J; Frich JR
    Immunology; 1979 Feb; 36(2):279-91. PubMed ID: 437832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of DNA/anti-DNA complexes. III. Kinetic control of immune complex size.
    Taylor RP; Waller SJ; Haden C; Addis DJ
    J Immunol; 1980 Jun; 124(6):2571-7. PubMed ID: 7373039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and characterization of immune complexes by the platelet aggregation test. I. Complexes formed in vitro.
    Penttinen K; Vaheri A; Myllylä G
    Clin Exp Immunol; 1971 Mar; 8(3):389-97. PubMed ID: 5576659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of monocyte complement component synthesis by antigen--antibody complexes.
    McPhaden A; Lappin D; Whaley K
    Immunology; 1981 Sep; 44(1):193-200. PubMed ID: 7275185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced degradation of soluble immune complexes by guinea-pig peritoneal macrophages in the presence of complement.
    Kijlstra A; van Es LA; Daha MR
    Immunology; 1981 Jun; 43(2):345-52. PubMed ID: 7251057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent monocyte-mediated cytotoxicity. The interference by platelets, immune complexes, and normal serum.
    Kragballe K; Ellegaard J; Herlin T
    Scand J Haematol; 1980 Jul; 25(1):67-75. PubMed ID: 7444375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of mononuclear phagocyte function in the rat. I. Saturation and recovery following intravenous administration of soluble human serum albumin (HSA)--anti-HSA complexes.
    Bourne JT; Raynor WJ; Verrier Jones J
    Clin Exp Immunol; 1983 Jan; 51(1):69-76. PubMed ID: 6831772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measurement of circulating thyroglobulin antithyroglobulin immune complex in thyroid diseases and its clinical implication (author's transl)].
    Endo Y; Ohtaki S
    Rinsho Byori; 1982 Feb; 30(2):138-44. PubMed ID: 7045467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.